ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Internal Medicine

Top Internal Medicine Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GIOVANNI BAULA M.D.

Internal Medicine

26,038

$1.8M

1080
883 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

17%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$69
Average prescription price

Avg: $56

RICARDO MARIN MD

Internal Medicine

26,017

$896K

813
734 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$34
Average prescription price

Avg: $56

ENRIQUE CUE-GALVEZ MD

Internal Medicine

25,539

$907K

763
725 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

4%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$36
Average prescription price

Avg: $56

ILDEFONSO GOMEZ M.D.

Internal Medicine

25,510

$882K

1317
1202 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$35
Average prescription price

Avg: $56

JOHN BATISTA M.D.

Internal Medicine

25,461

$783K

1061
931 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 8%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 25%

$31
Average prescription price

Avg: $56

JAVIER PEREZ MD

Internal Medicine

25,451

$2.06M

549
450 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 25%

$81
Average prescription price

Avg: $56

JOSE POLANCO M.D., P.A.

Internal Medicine

25,232

$1.11M

985
762 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

23%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $56

ANDREW SCANAMEO M.D.

Internal Medicine

25,205

$1.53M

714
585 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

17%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $56

JOSE DIAZ M.D.

Internal Medicine

24,838

$2.05M

486
421 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 25%

$83
Average prescription price

Avg: $56

JAY RAYAN MD PA

Internal Medicine

24,748

$607K

946
887 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 25%

$25
Average prescription price

Avg: $56

BARRY RODWICK M. D.

Internal Medicine

24,740

$8.92M

401
36 are 65+

17%
patients receiving schedule two controlled substances

Avg: 5%

35%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 25%

$361
Average prescription price

Avg: $56

RALPH PAGE M.D.

Internal Medicine

24,569

$1.48M

601
345 are 65+

42%
patients receiving schedule two controlled substances

Avg: 5%

22%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $56

BRADLEY TAN M.D.

Internal Medicine

24,507

$1.42M

1250
1024 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $56

KENNETH NEIFELD M.D.

Internal Medicine

24,377

$1.24M

782
632 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

22%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $56

KHURSHID AHMED MD

Internal Medicine

24,349

$954K

929
730 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$39
Average prescription price

Avg: $56

PARAG PITRODA MD

Internal Medicine

24,317

$875K

774
656 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

17%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$36
Average prescription price

Avg: $56

PRATIMA DESHMUKH M.D.

Internal Medicine

24,120

$853K

1210
1030 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 25%

$35
Average prescription price

Avg: $56

MIR A ALIKHAN MD

Internal Medicine

24,014

$615K

833
780 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$26
Average prescription price

Avg: $56

ANTONIO CARDONA MD

Internal Medicine

24,004

$1.02M

583
514 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

4%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$43
Average prescription price

Avg: $56

CARLOS CONRADO M.D.,

Internal Medicine

24,003

$1.24M

705
544 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $56

BETH BRAVER M.D.

Internal Medicine

23,889

$1.36M

1122
850 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $56

ALEXANDER LOPEZ-ALVAR M.D.

Internal Medicine

23,734

$776K

940
786 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$33
Average prescription price

Avg: $56

PANKAJ JOSHI MD

Internal Medicine

23,711

$1.38M

542
391 are 65+

18%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $56

RAFAEL CHIONG MD

Internal Medicine

23,667

$960K

601
550 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$41
Average prescription price

Avg: $56

DANIEL HEINIG M.D.

Internal Medicine

23,634

$920K

980
840 are 65+

14%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$39
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank